Treatt sees FY pre-tax profits reverting to 'more normal' H2 weighting

Chemicals firm Treatt said on Friday that against the backdrop of last year's "unusually strong" first half, it expects 2022's pre-tax profit to revert to "a more normal" second-half weighting, reflecting the seasonality of beverage consumption in the Northern Hemisphere.

However, Treatt stated it had made a good start to the new financial year, with its order book up strongly year-on-year.

The London-listed firm said its business was continuing to grow across multiple categories, reflecting its increasing investment in research and development and the firm's relevance with prevalent consumer beverage trends, particularly the growing demand for healthier, natural products.

Elsewhere, Treatt noted that its move to a new UK-based headquarters was progressing as planned and would provide it with "substantial extra capacity" in coming years to grow with enhanced efficiency and an emphasis on sustainability.

Treatt added that it was looking forward to the remainder of the financial year and beyond "with confidence".

As of 0805 GMT, Treatt shares were down 2.63% at 1,110.0p.